James W. Kesterson is a notable inventor based in Libertyville, IL (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of LHRH analogs. With a total of 2 patents, Kesterson's work has the potential to impact therapeutic approaches in various medical applications.

Latest Patents

Kesterson's latest patents include innovative formulations that enhance the delivery of LHRH analogs. The first patent focuses on novel solution and suspension aerosol formulations comprising LHRH analogs. The second patent also relates to aerosol formulations, which include LHRH analogs, a lipophilic counterion, solvent, and propellant, along with optional components such as surfactants, valve lubricants, antioxidants, and flavor and fragrance.

Career Highlights

James W. Kesterson is currently associated with Abbott Laboratories Corporation, a leading global healthcare company. His work at Abbott has allowed him to explore and develop advanced pharmaceutical solutions that address critical health issues.

Collaborations

Kesterson has collaborated with esteemed colleagues, including Akwete L. Adjei and Edwin Samuel Johnson. These partnerships have fostered a collaborative environment that enhances innovation and research in the field.

Conclusion

James W. Kesterson's contributions to the field of pharmaceutical formulations, particularly through his patents on LHRH analogs, demonstrate his commitment to advancing medical science. His work continues to pave the way for new therapeutic options in healthcare.

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]